Cancerous tumors carry certain markers called neoantigens and Facebook billionaire Sean Parker wants to use algorithms to find them. To do so, the Parker Institute for Cancer Immunotherapy will work with more than 30 public and private pharmaceutical, biotech, cancer research nonprofits and academic institutions through a partnership with the Cancer Research Institute to use predictive algorithms to help uncover new cancer neoantigens found coded in DNA.
Sean Parker is partnering with the Cancer Research Institute to find a cancer vaccine
My Health eNews
- Choose the news you want from more than two dozen topics.
- Medically-reviewed health news drawn from 350+ sources, delivered monthly to your inbox.
- Your username and password ensure your personalized news is delivered only to you.